Moderna
Cambridge · Founded 2010
About Moderna
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $4.6B
- Funding stage: IPO
- Last round: Grant (Dec 2025)
- Ticker: nasdaq:MRNA
- Website: modernatx.com
- Phone: 617-714-6500
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/moderna-91159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.